Cumulatively, our results indicated that FoxM1 silencing in resistant HCC cells effectively sensitized them to the tumor suppressive activities of Artemisinin, reflected by their attenuated neoplastic transformations and enhanced apoptosis. The gene discussed is FOXM1; the disease is neoplasm.